High-flow nasal cannula oxygen therapy versus conventional oxygen therapy in patients undergoing bronchoscopy: a retrospective study
The use of HFNC therapy can effectively reduce the incidence of SpO<sub>2</sub> < 90% during bronchoscopy in patients with hypoxemia. Additionally, HFNC significantly reduces the overall incidence of adverse events compared to COT. In patients with milder hypoxemia, its advantages in maintaining operational stability during bronchoscopy should not be overlooked.
Authors
- Xiaohui Luo (ORCID: https://orcid.org/0000-0001-9801-5099)
- Fei Xiang (ORCID: https://orcid.org/0000-0002-7134-9459)
Institutions
- Union Hospital (HK)
- Wuhan Union Hospital (CN)
- Union Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1186/s12890-024-03440-9
- Citations
- 6
- Primary Topic
- Respiratory Support and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 2.51